|
|
|
|
[external] Coughing Is Bad for Amgen's Health
For all you investors out there, remember there are three steps to getting a drug on the market in the U.S.: getting subjects enrolled in the clinical trial, meeting the trial's endpoints, and getting approved by the Food and Drug...
|
|
|
CTS: Gefitinib Superior to Chemotherapy Among Asians with Lung Cancer
Tony Mok, M.D., Chinese University of Hong Kong CHCIAGO, Nov.17 -- For carefully selected Asian patients with non-small-cell lung cancer, the tyrosine kinase inhibitor gefitinib (Iressa) significantly improved progression-free survival...
|
|
|
CTS: High Lung Cancer Response Rate Seen with Three-Drug Regimen Plus Cetuximab
CHICAGO, Nov.14 -- Augmenting the standard therapy for non-small-cell lung cancer with cetuximab (Erbitux) is both safe and surprisingly effective, researchers said here. In a phase II trial, 'we observed the largest response in non...
|
|
|
Four drug combination helps in lung cancer: U.S. study
Washington, November 13 (MIA) - Combining two chemotherapy drugs with two targeted therapies was safe and appeared to help patients with advanced lung cancer live longer, U.S.researchers reported on Thursday. The combination of Roche...
|
|
|
Four drug combination helps in lung cancer: U.S. study (Reuters)
WASHINGTON (Reuters) Combining two chemotherapy drugs with two targeted therapies was safe and appeared to help patients with advanced lung cancer live longer, U.S.researchers reported on Thursday. The combination of Roche and Co's...
|
|
|
Four drug combination helps in lung cancer: U.S. study
WASHINGTON (Reuters) - Combining two chemotherapy drugs with two targeted therapies was safe and appeared to help patients with advanced lung cancer live longer, U.S.researchers reported on Thursday. The combination of Roche and Co's...
|
|
|
Four drug combination helps in lung cancer: U.S. study
By Maggie Fox, Health and Science Editor WASHINGTON (Reuters) - Combining two chemotherapy drugs with two targeted therapies was safe and appeared to help patients with advanced lung cancer live longer, U.S.researchers reported on...
|
|
|
Four drug combination helps in lung cancer: U.S. study
WASHINGTON (Reuters) - Combining two chemotherapy drugs with two targeted therapies was safe and appeared to help patients with advanced lung cancer live longer, U.S.researchers reported on Thursday. The combination of Roche and Co's...
|
|
|
Four drug combination helps in lung cancer-US study
WASHINGTON, Nov 13 (Reuters) - Combining two chemotherapy drugs with two targeted therapies was safe and appeared to help patients with advanced lung cancer live longer, U.S.researchers reported on Thursday. The combination of Roche ...
|
|
|
Four drug combination helps in lung cancer-US study
By Maggie Fox, Health and Science Editor WASHINGTON, Nov 13 (Reuters) - Combining two chemotherapy drugs with two targeted therapies was safe and appeared to help patients with advanced lung cancer live longer, U.S.researchers reported on...
|
|
|
Four drug combination helps in lung cancer-US study
By Maggie Fox, Health and Science Editor WASHINGTON, Nov 13 (Reuters) - Combining two chemotherapy drugs with two targeted therapies was safe and appeared to help patients with advanced lung cancer live longer, U.S.researchers reported on...
|
|
|
Sun Pharma gets US approval for Paraplatin injection
Sun Pharmaceutical Industries Ltd Tuesday said it has got the US Food and Drug Administration (USFDA) approval for the abbreviated new drug application (ANDA) to market generic Paraplatin, a carboplatin injection.These generic...
|
|
|
Sun Pharma gets US FDA nod for generic Paraplatin injection
Sun Pharmaceutical Industries Ltd announced that US FDA has granted an approval for the Abbreviated New Drug Application (ANDA) to market generic Paraplatin, carboplatin injection.These generic versions of carboplatin 10mg/ml...
|
|
|
Sun Pharmaceutical Announces USFDA Approval to Market Generic Paraplatin Injection
MUMBAI, India, Sept.23, 2008: Sun Pharmaceutical Industries Ltd. announced that USFDA has granted an approval for the Abbreviated New Drug Application (ANDA) to market generic Paraplatin , carboplatin injection. These generic...
|
